SUBSCRIBERS
Teva said to be close to buying generic drug unit of Allergan
Published Sun, Jul 26, 2015 · 09:50 PM
Petah Tikva, Israel
TEVA Pharmaceuticals is in advanced talks to buy the generic drug division of Allergan for about US$45 billion, a person briefed on the matter said on Saturday.
A deal could be announced as soon as Monday, this person said, though talks are ongoing and may still fall apart. Should an agreement be reached, it would be the latest hu…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Prada’s sales up 16% in first quarter as Miu Miu shines
Toymaker Hasbro posts quarterly profit beat, slower sales decline
Hilton lifts 2024 profit forecast on international travel demand
China knockoff raid jolts a global throng of fake-fashion influencers
Roche cuts pipeline after research setbacks and sales drop
Cordlife customers push for legal action